Robotic Liver Resection as a Bridge to Liver Transplantation by Panaro, Fabrizio et al.
Robotic Liver Resection as a Bridge to Liver
Transplantation
Fabrizio Panaro, Tullio Piardi, Murat Cag, Jacques Cinqualbre, Philippe Wolf, Maxime Audet
ABSTRACT
Background: The surgical robotic system is superior to
traditional laparoscopy in regards to 3-dimensional im-
ages and better instrumentation. Robotic surgery for he-
patic resection has not yet been extensively reported. The
aim of this article is to report the first known case of liver
resection with the use of a robot in France.
Methods: A 61-year-old male with hepatitis C liver cirrho-
sis and hepatocellular carcinoma was referred for surgical
treatment. Preoperative clinical evaluation and laboratory
data disclosed a Child-Pugh class A5 patient. Magnetic
resonance imaging showed a 3.4-cm tumor in segment III.
Liver size was normal, and there were not signs of portal
hypertension. Five trocars were used.
Results: Liver transection was achieved with Harmonic
scalpel and bipolar forceps without pedicle clamping.
Hemostasis of raw surface areas was accomplished with
interrupted stitches. Operative time was 180 minutes.
Blood loss was minimal, and the patient did not receive
transfusion. The recovery was uneventful, and the patient
was discharged on the fifth postoperative day without
ascites formation.
Conclusion: The robotic approach may enable liver re-
section in patients with cirrhosis. The da Vinci robotic
system allowed for technical refinements of laparoscopic
liver resection due to 3-dimensional visualization of the
operative field and instruments with wrist-type end-effec-
tors.
Key Words: Hepatocellular carcinoma, Robotic liver re-
section.
INTRODUCTION
The development of minimally invasive surgery has led to
an increase in laparoscopic hepatic resection. Particularly
for hepatocellular carcinoma (HCC), in which the possi-
bility of repetitive surgery for cancer recurrence or liver
transplantation is high, the laparoscopic approach results
in less postoperative adhesion than with open abdominal
surgery, decreasing the difficulty of dissection in future
operations.
However, laparoscopy is limited by 2-dimensional imaging
and restricted instrument motion. Advanced computer tech-
nology has been developed to overcome these limitations.
The surgical robotic system provides 3-dimensional images,
allowing surgeons to operate with advanced vision. More-
over, the robotic system utilizes Endo-Wrist, an instrument
with a 360-degree range of motion.
Currently, Intuitive Surgical, Mountain View, CA, USA, is
the only company to produce a robotic surgical device.1
There have been few reports discussing the indications of
robotic surgery in hepatobiliary procedures, and robotic
surgery in hepatic resection has not been extensively
reported. Herein, we present the first case of da Vinci
robotic liver resection reported in France, “the land of
laparoscopy.”
METHODS
A 61-year-old male (JT) with a 30-year history of hepatitis
C was admitted to the hospital for HCC in segment III of
the liver. Serum alpha-fetoprotein (AFP) level was 150UI/
mL. The patient had liver cirrhosis corresponding to Child-
Pugh class A5, and the Indocyanine Green retention rate
at 15 minutes (ICG-R 15) was 1.3%. The computed tomog-
raphy (CT) scan and magnetic resonance imaging (MRI)
revealed a 3.4-cm single mass in segment III consistent
with HCC (Figure 1).
Surgical Technique
While under general anesthesia, the patient was placed in
a supine position, and 5 trocars were used. Pneumoperi-
toneum to 13mm Hg was established. A 12-mm trocar for
the robotic camera was placed above the umbilicus by the
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CASE REPORTHasson method (open technique). Three additional 8-mm
trocars were placed at the left upper quadrant (LUQ),
epigastric, and right upper quadrant (RUQ) areas under
the optic guidance, respectively. A 10-mm trocar for an
assistant was also placed at the LUQ area. The 4-arm da
Vinci surgical robot system was brought into position and
docked following port placement. The operator moved to
the console to control the robotic arms. The assistant on the
patient’s left side changed the robotic instruments and per-
formed intraoperative ultrasonography through the 10-mm
LUQ trocar site (Figure 2).
A 30° robotic camera was used. After exploration of the
abdominal cavity, intraoperative ultrasonography was
used to examine the remaining liver to search for unde-
tectable lesions and obtain adequate surgical resection
margins. The undissected round ligament was used to
retract the liver. The liver was mobilized by cutting the left
triangular ligament and lesser omentum. Parenchymal di-
vision proceeded from the anterior edge of the liver by
Harmonic scalpel and bipolar electrocautery. The small
vessels and bile ducts exposed during parenchymal dis-
section were ligated and divided by clipping. The Glis-
son’s pedicles of segments III was clamped and divided
by suture technique. Pringle’s maneuver was not applied
during the entire procedure. A closed suction drain cath-
eter was placed in the left subhepatic space. The speci-
men was placed in an endoscopic retrieval bag and re-
moved through a midline mini-laparotomy incision
(length: 5cm) extending from the port site.
Postoperative Course and Outcomes
The postoperative period was uneventful (Table 1). After
the hepatic resection, the hospitalization lasted for 5 days
although recovery was observed at postoperative day 3. A
clear liquid diet was started on postoperative day 1. Path-
ological examination demonstrated a 3.5-cm HCC without
capsular invasion and focal micro-vessel invasion. The
resection margin was free of carcinoma, and the distance
was 0.9cm. After 4 months, the patient was doing well,
without HCC recurrence on CT scan (Figure 3). The AFP
level was 6UI/mL.
DISCUSSION
Robotic surgery enables the surgeon to control the robotic
system and to perform more precise and complex opera-
tions. The da Vinci Surgical System provides operators
with (1) intuitive translation of the instrument handle to
the tip movement, (2) visualization with 3-dimensional
images and stable camera platform, (3) scaling, (4) tremor
filtering, (5) coaxial alignment of eyes, hand, and tool tip
images, (6) Endo-Wrist with a 360-degree range of mo-
tion, (7) comfortable, ergonomically ideal operating posi-
tion, and (8) the possibility of remote site surgery.1–4
Robotic liver surgery provides access to fine structures of
the liver and allows surgeons to see delicate blood vessels
Figure 1. CT scan (B) shows a 3.4-cm mass consistent with HCC
in segment III. HCC: hepatocellular carcinoma.
Figure 2. Trocar placement.
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tage of improved depth perception and accuracy.5 Fur-
thermore, the robotic system involves minimal intraoper-
ative manipulation of the tumor mass, resulting in less
trauma and risk of cancer dissemination.
However, robotic surgery has several limitations: (1) high
cost, (2) lack of tactile sense, (3) lack of training systems,
(4) heavy robotic arms and equipment, (5) time-consum-
ing setup, and (6) difficulty in converting to open sur-
gery.2,3,6 Furthermore, the da Vinci system is not attached
to the operating table, requiring undocking to change
table position. When perilous circumstances such as mas-
sive bleeding occur, the assistant can compress bleeding
focus with laparoscopic instruments until conversion to
open surgery. Problems will most likely be resolved as
computer-enhanced technology continues to develop and
surgeons accumulate experience.
Currently, the da Vinci robotic system is applied to
almost every surgical procedure. Evaluation of robotic-
assisted surgery in other fields such as prostate cancer
or colorectal disease was proven to be safe and feasible.
Oncological and functional outcomes are promis-
ing.4,7–10 In the laparoscopic era, no controlled random-
ized clinical trials have been performed comparing lap-
aroscopy with open hepatic resection in terms of safety,
feasibility, and efficacy. Simillis et al11 investigated lapa-
roscopic versus open hepatic resection for hepatic can-
cer through a meta-analysis and concluded that opera-
tive blood loss and duration of hospital stay were
significantly reduced after laparoscopic surgery and
that there was no difference in postoperative adverse
events or the extent of oncological clearance. Vibert et
al12 concluded after 10 years of experience in perform-
ing laparoscopic liver surgery that the results of lapa-
roscopy are similar to those of laparotomy, suggesting
that the laparoscopic approach could be used for major
hepatectomy also in case of malignancy. Moreover,
Chang et al13 advocate that laparoscopic left lateral
sectionectomy for benign or malignant neoplasm is safe
and feasible and can be considered as a routine ap-
proach in select patients. However, there have been
few reports about robotic hepatic resection.
In our experience, operative time was longer due to
unfamiliarity with robotic instruments and setup time.
However, the length of time required will continue to
decrease as surgeons become more familiar with the
procedure. In patients with small malignant tumors and
benign diseases, robotic resection is feasible. Further-
more, we expect that accumulating experience will
make it possible to safely perform other hepatectomies.
We found shorter length of hospital stays, earlier start of
oral feeding and less pain after robotic surgery com-
pared to open surgery for liver resection.
From the oncologic point of view, the potential benefits of
a minimally invasive approach in terms of curability, re-
currence, and long-term survival are inconclusive.14 Nev-
ertheless, to perform anatomical resection with safe resec-
tion margins, intraoperative laparoscopic ultrasonography
Table 1.
Operative and Postoperative Outcomes
Port Location Camera Above the umbilicus
Assistant: LPU
Cannula: RUQ, LUQ, RPU
a
Operative Time* (min) 178
Blood Loss (mL) 230
Transfusion (unit) 0
Associated Procedures Cholecystectomy (lithiasis)
Hospital Stay (days) 5
Time to Start Diet
Liquid First day
Solid Second day
Complications None
aRUQRight Upper Quadrant; LUQLeft Upper Quadrant;
RPURight Paraumbilical; LPU Left Paraumbilical. *Operative
time for surgery.
Figure 3. The CT-scan after 4 months of follow-up did not show
HCC recurrence.
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location and adjacent vascular or biliary involvement ex-
cluding adjunctive lesions.15
CONCLUSION
The da Vinci robotic hepatic resection can open a new
horizon of treatment strategies and overcome the limi-
tations of laparoscopic surgery. In the near future, the
use of robots is expected to increase in the treatment of
malignant tumors of the liver as a minimally invasive
surgery.
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